Dyne Therapeutics Stock Rises 40% in a Year, but Saturn V Fund Reduces Holdings May 20, 2026 Life Science
Eli Lilly Stock Hits Bottleneck After 400% Surge in Five Years, Novo Nordisk Poised for a Comeback with 4% Dividend Yield May 8, 2026 Life Science
Dark Horse in the Weight-Loss Drug Arena? Viking Therapeutics Has Potential Upside of Over 200% May 4, 2026 Life Science
From Weight Loss to Cancer Treatment Drugs, Eli Lilly Has More Than One Ace in the Hole Apr 28, 2026 Life Science
Aaron Wealth Advisors Increases Stake in MBX Biosciences, Betting on Precision Peptide Therapies for Rare Diseases Apr 23, 2026 Life Science
UnitedHealth’s Q1 Performance Exceeds Expectations, Early Returns Seen from AI Investments Apr 21, 2026 Life Science
